Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-11 · accession 0001209191-22-018693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-15 | 2022-03-11 | USPH | READING CHRISTOPHER J | CEO, Dir | A - Grant | $0.00 | +20.0K | 89.6K | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-11 | A | A | 20,000 | $0.00 | 89,638 | D | — | — | (F1) The 20,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installments with the first 1,250 shares on April 1, 2022 and with the final 1,250 shares lapsing on January 1, 2026, if he is employed by the Company on those dates. (F2) Includes the 20,000 shares in Footnote 1 and includes 20,711 shares which restrictions lapse as to 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. |